Bill Sponsor
Senate Bill 77
117th Congress(2021-2022)
Protecting Life and Integrity in Research Act of 2021
Introduced
Introduced
Introduced in Senate on Jan 28, 2021
Overview
Text
Introduced in Senate 
Jan 28, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Jan 28, 2021)
Jan 28, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
S. 77 (Introduced-in-Senate)


117th CONGRESS
1st Session
S. 77


To amend the Public Health Service Act to prohibit the Secretary of Health and Human Services from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and for other purposes.


IN THE SENATE OF THE UNITED STATES

January 28, 2021

Mrs. Hyde-Smith (for herself, Mr. Barrasso, Mrs. Blackburn, Mr. Boozman, Mr. Cotton, Mr. Cramer, Mr. Daines, Mrs. Fischer, Mr. Hawley, Mr. Inhofe, Mr. Lankford, Ms. Lummis, Mr. Moran, Mr. Portman, Mr. Risch, Mr. Rounds, Mr. Scott of South Carolina, Mr. Cruz, Mr. Marshall, Mr. Braun, Mr. Kennedy, and Mr. Lee) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions


A BILL

To amend the Public Health Service Act to prohibit the Secretary of Health and Human Services from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protecting Life and Integrity in Research Act of 2021”.

SEC. 2. No research by HHS involving human fetal tissue obtained pursuant to an induced abortion.

(a) In general.—The Public Health Service Act is amended by inserting after section 498A of such Act (42 U.S.C. 289g–1) the following:

“SEC. 498A–1. No research involving human fetal tissue obtained pursuant to an induced abortion.

“(a) In general.—The Secretary may not conduct or support any research involving human fetal tissue that is obtained pursuant to an induced abortion.

“(b) Development of new, ethical cell lines.—Subsection (a) does not limit the authority of the Secretary to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion.”.

(b) Conforming amendments.—Section 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended—

(1) in subsections (a)(2), (c)(1)(B), and (g), by striking “or induced” each place it appears; and

(2) in subsection (b)(2)—

(A) by striking subparagraph (A); and

(B) by redesignating subparagraphs (B) and (C) as (A) and (B), respectively.

SEC. 3. Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion.

(a) In general.—Paragraph (1) of section 498B(c) of the Public Health Service Act (42 U.S.C. 289g–2(c)) is amended to read as follows:

“(1) solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—

“(A) a human pregnancy was deliberately initiated to provide such tissue; or

“(B) the tissue was obtained pursuant to an induced abortion; or”.

(b) Conforming changes.—Section 498B of the Public Health Service Act (42 U.S.C. 289g–2) is amended—

(1) by striking subsection (b);

(2) by redesignating subsections (c) through (e) as subsections (b) through (d), respectively;

(3) in subsection (c), as redesignated—

(A) in paragraph (1), by striking “(a), (b), or (c)” and inserting “(a) or (b)”; and

(B) in paragraph (2), by striking “or (b)(3)”; and

(4) in subsection (d), as redesignated, by amending paragraph (1) to read as follows:

“(1) The term ‘human fetal tissue’ means tissue or cells obtained from a dead human embryo or fetus after a spontaneous or induced abortion, or after a stillbirth.”.

SEC. 4. Authorization for HHS research on fetal tissue and corresponding reporting.

Section 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended—

(1) in the section heading, by striking “Research on transplantation of fetal tissue” and inserting “Research on fetal tissue”;

(2) in subsection (a)(1)—

(A) by striking “research on the transplantation of human fetal tissue for therapeutic purposes” and inserting “research on human fetal tissue”; and

(B) by adding at the end the following: “Notwithstanding any other provision of law, any research of the Department of Health and Human Services on human fetal tissue shall be conducted or supported in accordance with this section.”; and

(3) in subsection (b)(1)(B), by inserting “if the fetal tissue is intended for transplantation,” before “the donation is made”.